Cytochrome P450 reductase from Candida apicola: versatile redox partner for bacterial P450s

Girhard, Marco; Tieves, Florian; Weber, Evelyne; Smit, Martha; Urlacher, Vlada
February 2013
Applied Microbiology & Biotechnology;Feb2013, Vol. 97 Issue 4, p1625
Academic Journal
Candida apicola belongs to a group of yeasts producing surface-active glycolipids consisting of sophorose and long-chain (ω)- or (ω-1)-hydroxy fatty acids. Hydroxylation of the fatty acids in this strain is likely catalyzed by cytochrome P450 monooxygenases (P450), which require reducing equivalents delivered via a cytochrome P450-diflavin reductase (CPR). We herein report cloning and characterization of the cpr gene from C. apicola ATCC 96134. The gene encoding a protein of 687 amino acids was cloned in Escherichia coli and the enzyme was expressed in functional form after truncation of its N-terminal putative membrane anchor. The truncated recombinant protein showed cytochrome c reducing activity ( K of 13.8 μM and k of 1,915 per minute). Furthermore, we herein demonstrate to our best knowledge for the first time the use of a eukaryotic CPR to transfer electrons to bacterial P450s (namely CYP109B1 and CYP154E1). Cloning and characterization of this CPR therefore is not only an important step in the study of the P450 systems of C. apicola, but also provides a versatile redox partner for the characterization of other bacterial P450s with appealing biotechnological potential. The GenBank accession number of the sequence described in this article is JQ015264.


Related Articles

  • Clinical consequences of cytochrome P450 2C9 polymorphisms. Kirchheiner, Julia; Brockmöller, Jürgen // Clinical Pharmacology & Therapeutics;Jan2005, Vol. 77 Issue 1, p1 

    The gene coding for the cytochrome P450 (CYP) enzyme 2C9 (CYP2C9) carries numerous inherited polymorphisms. Those coding for R144C (*2) and I359L (*3) amino acid substitutions have both significant functional effects and appreciable high population frequencies, and their in vivo consequences...

  • Cytochrome P450 4A Fatty Acid Omega Hydroxylases. Okita, R.T.; Okita, J.R. // Current Drug Metabolism;Sep2001, Vol. 2 Issue 3, p265 

    The Cytochrome P450 4A subfamily is one of eighteen subfamilies in the CYP4 family and Presently consists of twenty individual forms in nine different mammalian species. The major substrates for CYP4A forms are fatty acids, but recent studies have shown other non-fatty acid substrates may be...

  • Characterization of the versatile monooxygenase CYP109B1 from Bacillus subtilis. Girhard, Marco; Klaus, Tobias; Khatri, Yogan; Bernhardt, Rita; Urlacher, Vlada B. // Applied Microbiology & Biotechnology;Jun2010, Vol. 87 Issue 2, p595 

    The oxidizing activity of CYP109B1 from Bacillus subtilis was reconstituted in vitro with various artificial redox proteins including putidaredoxin reductase and putidaredoxin from Pseudomonas putida, truncated bovine adrenodoxin reductase and adrenodoxin, flavodoxin reductase and flavodoxin...

  • Role of residue 87 in substrate selectivity and regioselectivity of drug-metabolizing cytochrome P450 CYP102A1 M11. Vottero, Eduardo; Rea, Vanina; Lastdrager, Jeroen; Honing, Maarten; Vermeulen, Nico; Commandeur, Jan // Journal of Biological Inorganic Chemistry;Aug2011, Vol. 16 Issue 6, p899 

    CYP102A1, originating from Bacillus megaterium, is a highly active enzyme which has attracted much attention because of its potential applicability as a biocatalyst for oxidative reactions. Previously we developed drug-metabolizing mutant CYP102A1 M11 by a combination of site-directed and random...

  • Engineering, expression, and purification of “soluble” human cytochrome P45017α and its functional characterization. Pechurskaya, T.; Lukashevich, O.; Gilep, A.; Usanov, S. // Biochemistry (00062979);Jul2008, Vol. 73 Issue 7, p806 

    To engineer a “soluble” form of membrane-bound cytochrome P45017α (CYP17)—a key enzyme in steroid hormone biosynthesis—in the present work we have built a computer model of the tertiary structure of the hemeprotein, identified the surface hydrophobic amino acid...

  • Coupled Motions Direct Electrons along Human Microsomal P450 Chains. Pudney, Christopher R.; Khara, Basile; Johannissen, Linus O.; Scrutton, Nigel S. // PLoS Biology;Dec2011, Vol. 9 Issue 12, p1 

    Protein domain motion is often implicated in biological electron transfer, but the general significance of motion is not clear. Motion has been implicated in the transfer of electrons from human cytochrome P450 reductase (CPR) to all microsomal cytochrome P450s (CYPs). Our hypothesis is that...

  • A novel membrane-anchored cytochrome c-550 of alkaliphilic Bacillus clarkii K24-1U: expression, molecular features and properties of redox potential. Ogami, Shinichi; Hijikata, Shoichi; Tsukahara, Tamotsu; Mie, Yasuhiro; Matsuno, Toshihide; Morita, Naoki; Hara, Isao; Yamazaki, Koji; Inoue, Norio; Yokota, Atsushi; Hoshino, Tamotsu; Yoshimune, Kazuaki; Yumoto, Isao // Extremophiles;May2009, Vol. 13 Issue 3, p491 

    A membrane-anchored cytochrome c-550, which is highly expressed in obligately alkaliphilic Bacillus clarkii K24-1U, was purified and characterized. The protein contained a conspicuous sequence of Gly22-Asn34, in comparison with the other Bacillus small cytochromes c. Analytical data indicated...

  • The dose-dependent influence of antioxidant vitamins on electrochemically-driven cytochrome P450 3A4 catalysis. Shumyantseva, Victoria V.; Makhova, Anna A.; Bulko, Tatyana V.; Kuzikov, Alexey V.; Shich, Evgeniya V.; Suprun, Elena V.; Kukes, Vladimir; Usanov, Sergei; Archakov, Alexander // Oxidants & Antioxidants in Medical Science;Jun2013, Vol. 2 Issue 2, p113 

    Electrochemical analysis of the catalytic activity of cytochrome P450 3A4 has shown that vitamins C, A and E exert influence on the Fe3+/Fe2+ reduction process of this enzyme. Direct electron transfer of cytochrome P450 3A4 was investigated by use of cyclic voltammetry and square wave...

  • An Adamantanone Derivative That Is an Original Modulator of Redox Processes in the Cytochrome P-450 System Can Serve as an Effective Remedy Against Obliterating Angiopathy of Lower Extremities. Kovalev, I. E.; Koshkin, V. M.; Shipulina, N. V.; Rumyantseva, E. I. // Doklady Biochemistry & Biophysics;Jul/Aug2003, Vol. 391 Issue 1-6, p201 

    Presents a study which discussed the adamantanone derivative that is an original modulator of redox processes in the cytochrome P-450 system which can serve as an effective remedy against obliterating angiopathy of lower extremities. Description of the cytochrome P-450 system of the human and...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics